Welcome to the e-CCO Library Archive!
Interleukin 35 and 37 Intestinal Expression and Peripheral Synthesis by Subsets of Regulatory Cells in Patients with Inflammatory Bowel Disease.
G. Fonseca Camarillo*1, F.-C. Janette2, Y.F. Jesús Kazuo3
1Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán. México D.F, México., Inflammatory Bowel Disease Clinic. Department of Gastroenterology. , Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán. México D.F, México., Department of Gastroenterology, Mexico City, Mexico, 3Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán. México D.F, México., Inflammatory Bowel Disease Clinic. Department of Gastroenterology., Mexico City, Mexico
Healing of TNBS-induced colitis in the rat by peptide Hp(2-20)
M. Romano1, A.G. Gravina1, A. Federico1, G. D'Argenio2, C. Tuccillo1, A. Miranda1, N. Prevete3, A. De Paulis3, C. Loguercio1, 1Second University of Naples, Gastroenterology Unit, Department of Clinical and Experimental Medicine, Naples, Italy, 2Federico II University of Naples, Gastroenterology Unit, Department of Clinical and Experimental Medicine, Naples, Italy, 3Federico II University of Naples, Clinical Immunology and Allergy Division, Naples, Italy
J. Yamamoto-Furusho1, J. De-Leon-Rendon1, G. Vargas-Alarcon2, 1IBD Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico, 2Instituto Nacional de Cardiologia, Molecular Biology, Mexico
Ferrous sulphate but not iron polymaltose complex aggravates local and systemic inflammation and oxidative stress in DSS-induced colitis in rats
J.E. Toblli*, G. Cao, M. Angerosa
University of Buenos Aires, School of Medicine, Hospital Alemán, Laboratory of Experimental Medicine, Buenos Aires, Argentina
G protein-coupled receptor 30 expression in inflammatory bowel disease patients
A. Sobolewska1, M. Wlodarczyk1, A. Piechota-Polanczyk2, J. Fichna2, M. Wisniewska-Jarosinska1, 1Medical University of Lodz, Department of Gastroenterology, Lodz, Poland, 2Medical University of Lodz, Department of Biomolecular Chemistry, Lodz, Poland
F. Scaldaferri1, L.R. Lopetuso1, V. Petito1, V. Gerardi1, M. Bilotta2, A. Poscia3, M. Papi4, G. Maolucci5, V. Cufino6, E. Stigliano6, V. Arena6, G. Delogu2, M. Sanguinetti2, M. De Spirito4, A. Sgambato6, A. Gasbarrini1, 1Catholic University of Sacred Hearth, Internal Medicine, Gastroenterology Division, Rome, Italy, 2Catholic University of Sacred Hearth, Istitute of Microbiology, Rome, Italy, 3Catholic University of Sacred Hearth, Insitute of Hygiene, Rome, Italy, 4Catholic University of Sacred Hearth, Istitute of Phisics, Rome, Italy, 5Catholic University of Sacred Hearth, Institute of Phisics, Rome, Italy, 6Catholic University of Sacred Hearth, Institute of Pathology, Rome, Italy
Defining the aims of multi-disciplinary team driven care within an inflammatory bowel disease service provision - Results from a Delphi consensus-building methodology
A. Hart*1, N. Sevdalis2, J. Warusavitarne1, J. Green3, C. Edwards4, O. Faiz1
1St Mark's Hospital, Colorectal Surgery & IBD Unit, London, United Kingdom, 2Imperial College London, Surgery and Cancer, London, United Kingdom, 3University College Hospitals, Urology and Cancer, London, United Kingdom, 4Torbay Hospital, Gastroenterology, Torbay, United Kingdom
GLPG0634, the first selective JAK1 inhibitor, shows strong activity in the mouse DSS-colitis model
D. Merciris1, C. Delachaume2, V. De Vriendt3, A.-L. Boutet4, L. Perret1, M.-C. Ceccotti2, S. De Vos3, A. Monjardet4, R. Brys5, R. Galien6, 1Galapagos SASU, Histology, Romainville, France, 2Galapagos SASU, in vivo pharmacology, Romainville, France, 3Galapagos NV, Cell-based assays, Mechelen, Belgium, 4Galapagos SASU, DMPK, Romainville, France, 5Galapagos NV, Inflammation therapeutic area, Mechelen, Belgium, 6Galapagos SASU, Inflammation therapeutic area, Romainville, France
J. Bjerrum1, J. Olsen2, G. Rogler3, O. Nielsen1, 1Herlev Hospital, Department of Gastroenterology, Medical Section, Herlev, Denmark, 2Panum, Copenhagen University, Department of Cellular and Molecular Medicine, Copenhagen, Denmark, 3University Hospital Zürich, Division of Gastroenterology and Hepatology, Zürich, Switzerland
Flow cytometric detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease
M. Bendix*1, A. Dige1, B. Deleuran2, J.F. Dahlerup1, S.P. Jørgensen3, L.E. Bartels4, T. Harsløf5, L. Husted5, B. Langdahl5, J. Agnholt1
1Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark, 2Aarhus University, Institute of Biomedicine, Department of Immunology, Aarhus, Denmark, 3Regional Hospital Horsens, Department of Medicine, Horsens, Denmark, 4Aarhus University Hospital, Department of Rheumatology, Aarhus, Denmark, 5Aarhus University Hospital, Department of Endocrinology and Internal Medicine, Aarhus, Denmark
Fibrosis does not increase with disease duration in ulcerative colitis
J. de Bruyn1,2, S. Meijer3, M. Wildenberg1, G. van den Brink1,2, G. D'Haens2, 1Academic Medical Center, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands, 2Academic Medical Center, Gastroenterology & Hepatology, Amsterdam, Netherlands, 3Academic Medical Center, Pathology, Amsterdam, Netherlands